Standard Biotools Inc. SEC filings LAB

Standard Biotools Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jun 30, 2016. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 27, 2026 Dec 31, 2025
10-K Annual report Mar 16, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
10-K Annual report Mar 11, 2025 Dec 31, 2024
ARS Annual report to shareholders May 21, 2024 Dec 31, 2023
10-K/A Amended annual report Apr 26, 2024 Dec 31, 2023
10-K Annual report Mar 1, 2024 Dec 31, 2023
10-K Annual report Mar 14, 2023 Dec 31, 2022
10-K Annual report Mar 8, 2022 Dec 31, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
10-K/A Amended annual report Apr 29, 2020 Dec 31, 2019
10-K Annual report Feb 27, 2020 Dec 31, 2019
10-K Annual report Mar 18, 2019 Dec 31, 2018
10-K Annual report Mar 8, 2018 Dec 31, 2017
10-K/A Amended annual report Apr 28, 2017 Dec 31, 2016
10-K Annual report Mar 3, 2017 Dec 31, 2016

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LAB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
Accelerated filer
SEC CIK
1162194
Former names
FLUIDIGM CORP (until Apr 1, 2022)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.